Is the Rescheduling Order Safe? The D.C. Circuit Stay Risk

This is for the cautious medical cultivator who wants to take the deduction the rescheduling opened up but does not want to get burned if a court unwinds it. That worry is reasonable, and it deserves a straight answer rather than either of the two easy ones. The reckless answer is "it's settled, deduct everything." The overcautious answer is "wait until the litigation is over." Both are wrong for the same reason: they treat a live, moving situation as if it were finished. Here is what is actually happening in court, and what it means for the positions you put on your 2026 return.

Where the law stands today

Start with the part that is not in dispute. As of now, the DOJ/DEA order that moved state-licensed medical marijuana to Schedule III is in effect. It is controlling law. A qualifying medical operator is outside §280E for that activity going forward under current law, and taking that position is defensible precisely because the order is in force unless and until a court says otherwise. Nothing below changes that. The point of this article is not to talk you out of a legitimate position — it is to make sure you take it in a way that holds up if the ground shifts.

The legal challenges, in plain terms

Several petitions challenging the April 2026 final order have been filed and consolidated in the U.S. Court of Appeals for the D.C. Circuit. The lead challenger is MMJ International Holdings — a federally compliant pharmaceutical developer — together with co-petitioners. Their argument, in essence, is procedural: that the order was issued without following the proper steps and without the scientific review from Health and Human Services (HHS) that the challengers say the process required. You do not have to find that argument persuasive to take it seriously, and neither the court nor I have to agree with you about how it should come out. On the other side, state-licensed operators — the businesses actually benefiting from Schedule III — have moved to intervene in support of the government, precisely because they are relying on the order and want it to stand. That is the shape of the fight: a procedural challenge on one side, the operators who depend on the order on the other, and an appellate court that will actually decide it. This is not a fringe filing, which is why it deserves your attention without deserving your panic.

The stay risk — what a pause would do

The specific near-term risk is a stay. A request to stay the order pending review was filed on July 15, 2026 by petitioners including MMJ International Holdings and NDASA, and as of the current record it has not been granted. That last clause matters twice over: it means the order remains in force right now, and it means the situation is live — a stay could be granted, denied, or overtaken by events after this is written. If a stay were granted, it would suspend the order, which would revert medical cannabis to Schedule I and disrupt the §280E relief — and any DEA-registration steps — that operators have already begun to rely on. I am not predicting that outcome, and nothing here should be read as a forecast that the order will fall or that it is guaranteed to survive. The only responsible posture is to treat the stay as a real, unresolved possibility and to confirm the current status of the D.C. Circuit proceedings against the record before you act, because it may have moved since this was published.

The separate, broader rescheduling track

Running alongside the litigation is a different process worth not confusing with it. A DEA administrative law judge held an evidentiary hearing from June 29 to July 15, 2026 on whether all cannabis — including adult-use — should move to Schedule III. The key point for planning: the ALJ's recommendation is non-binding, a final rule would come later, and litigation is widely expected whichever way it goes. So the adult-use question is still open and slower-moving. Do not build this year's adult-use positions on the assumption that hearing has already changed the law, because it has not.

What this means for the positions you take now

Put it together and the play is a disciplined middle. Take the medical §280E-exempt position that current law allows — but take it as a documented position, not an assumption. That means supporting the allocation in workpapers and considering whether a Form 8275-R disclosure is appropriate, so the position is supported rather than unnecessarily exposed if it is ever examined (I cover both in companion guides). The logic is straightforward: if the order stands, you have taken a legitimate deduction and papered it cleanly; if the order is later stayed or vacated, a documented, disclosed position is far easier to unwind or defend than an aggressive one taken on faith. Documentation is the hedge that costs almost nothing and protects you in the one scenario you cannot control. It also means building the underlying cost work — the medical-versus-adult-use allocation and the §471 full-absorption analysis — so that it pays off regardless of how the scheduling question resolves. That work lowers your §280E exposure under any scenario, which is what makes it the safest money you can spend while the law is unsettled: it is not a bet on the litigation, it is insurance that holds either way.

The checklist

1. Take the medical §280E-exempt position that current law allows — and document the basis for it rather than treating it as settled.
2. Track the D.C. Circuit stay request; if a stay is granted, pause and re-evaluate before the 2026 return is filed, and confirm the current status against the record before you act.
3. Make the allocation and §471 work scenario-independent — it pays off whether or not the order survives.
4. Do not over-leverage the position — avoid irreversible financial commitments, like large distributions or expansions, made on the assumption the order is permanent.

The risk on both sides

There are two ways to get this wrong, and they point in opposite directions. Ignoring the litigation and treating the reschedule as bulletproof leaves you exposed if the order is stayed or later vacated. Freezing every position until the courts are finished is expensive and forfeits a deduction current law actually allows today. The disciplined answer is neither: take defensible positions now, document them so they survive scrutiny, and stay ready to adjust the moment the record changes.